Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practicePostgraduate medicine, 2022, Vol.134 (1), p.14-19 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2021.2002616Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysisAnnals of medicine (Helsinki), 2023-12, Vol.55 (2), p.2239830-2239830 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2239830 ;PMID: 37498865Full text available |
|
3 |
Material Type: Article
|
Recent advances in the treatment of patients with obesity and chronic kidney diseaseAnnals of medicine (Helsinki), 2023-12, Vol.55 (1), p.2203517-2203517 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2203517 ;PMID: 37086110Full text available |
|
4 |
Material Type: Article
|
Metformin use in hidradenitis suppurativaThe Journal of dermatological treatment, 2020-04, Vol.31 (3), p.261-263 [Peer Reviewed Journal]ISSN: 0954-6634 ;EISSN: 1471-1753 ;DOI: 10.1080/09546634.2019.1592100Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Recent developments in adjunct therapies for type 1 diabetesExpert opinion on investigational drugs, 2022-12, Vol.31 (12), p.1311-1320 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;ISSN: 1354-3784 ;EISSN: 1744-7658 ;DOI: 10.1080/13543784.2022.2159806Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Predictors of HbA1c reduction and hypoglycemia in type 2 diabetes mellitus individuals switching from premixed to basal insulin: an exploratory analysis of optimization studyCurrent medical research and opinion, 2022-11, Vol.38 (11), p.1807-1814 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2105538Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Profile of tirzepatide in the management of type 2 diabetes mellitus: design, development, and place in therapyExpert opinion on pharmacotherapy, 2023-03, Vol.24 (4), p.407-418 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;ISSN: 1465-6566 ;EISSN: 1744-7666 ;DOI: 10.1080/14656566.2023.2181074Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM)Expert opinion on pharmacotherapy, 2021-02, Vol.22 (3), p.373-387 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1465-6566 ;EISSN: 1744-7666 ;DOI: 10.1080/14656566.2020.1817388Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United StatesCurrent medical research and opinion, 2022-11, Vol.38 (11), p.1785-1795 [Peer Reviewed Journal]2022 Eli Lilly and Company. Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2085962Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Risk analysis of metformin use in prostate cancer: a national population-based studyThe aging male, 2023-12, Vol.26 (1), p.2156497-2156497 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1368-5538 ;EISSN: 1473-0790 ;DOI: 10.1080/13685538.2022.2156497 ;PMID: 36974927Full text available |
|
11 |
Material Type: Article
|
Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitusCurrent medical research and opinion, 2020-04, Vol.36 (4), p.571-581 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2019.1708287Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Long-term safety and effectiveness of linagliptin as add-on therapy in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillanceExpert opinion on drug safety, 2021-03, Vol.20 (3), p.363-372 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1474-0338 ;EISSN: 1744-764X ;DOI: 10.1080/14740338.2021.1859477Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetesVascular health and risk management, 2013-01, Vol.9 (default), p.155-163 [Peer Reviewed Journal]2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Ahrén, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s33934 ;PMID: 23637538Full text available |
|
14 |
Material Type: Article
|
Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort StudyInternational journal of chronic obstructive pulmonary disease, 2022-01, Vol.17, p.285-295 [Peer Reviewed Journal]2022 Tseng. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Tseng. 2022 Tseng. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S345796 ;PMID: 35177899Full text available |
|
15 |
Material Type: Article
|
Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special ConsiderationsDrug design, development and therapy, 2022-01, Vol.16, p.4449-4461 [Peer Reviewed Journal]2022 Chao et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Chao et al. 2022 Chao et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S365416 ;PMID: 36601368Full text available |
|
16 |
Material Type: Article
|
Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesisExpert opinion on drug safety, 2021-06, Vol.20 (6), p.707-720 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;ISSN: 1474-0338 ;EISSN: 1744-764X ;DOI: 10.1080/14740338.2021.1898585Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysisJournal of medical economics, 2020-06, Vol.23 (6), p.650-658 [Peer Reviewed Journal]2020 Novo Nordisk A/S. Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1369-6998 ;EISSN: 1941-837X ;DOI: 10.1080/13696998.2020.1722678Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Patient-reported outcomes in elderly patients with type 2 diabetes mellitus treated with dual oral therapy: a multicenter, observational study from ItalyCurrent medical research and opinion, 2020-04, Vol.36 (4), p.555-562 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2019.1707649Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Cardiovascular safety and effectiveness of vildagliptin in patients with type 2 diabetes mellitus: a 3-year, large-scale post-marketing surveillance in JapanExpert opinion on drug safety, 2020-05, Vol.19 (5), p.625-631 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1474-0338 ;EISSN: 1744-764X ;DOI: 10.1080/14740338.2020.1740679Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Practical guidance for use of oral semaglutide in primary care: a narrative reviewPostgraduate medicine, 2020-11, Vol.132 (8), p.687-696 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2020.1788340Digital Resources/Online E-Resources |